Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0LF3K
|
||||
| Former ID |
DIB010450
|
||||
| Drug Name |
A/Anhui/05
|
||||
| Synonyms |
Inactivated H5N1 avian influenza vaccine, NIAID
|
||||
| Drug Type |
Vaccine
|
||||
| Indication | Influenza virus [ICD10:J11.1] | Phase 1 | [1] | ||
| Company |
Glaxosmithkline; novavax; vaxart
|
||||
| Target and Pathway | |||||
| Target(s) | Hemagglutinin | Target Info | [2] | ||
| References | |||||
| REF 1 | ClinicalTrials.gov (NCT00912496) Booster Trial to 07-0019 With A/Anhui/05 With and Without MF59. U.S. National Institutes of Health. | ||||
| REF 2 | A Human Antibody Recognizing a Conserved Epitope of H5 Hemagglutinin Broadly Neutralizes Highly Pathogenic Avian Influenza H5N1 Viruses. J Virol. 2012 March; 86(6): 2978-2989. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.